Dr. Kevin Kelleher:

I am saying it is of that nature. If this vaccine turns out to be like MenC, we would want it in as soon as possible. However, I am saying there are some issues. In reality, it took us a year or so to plan for MenC after the decision for us to introduce it. We need time to make some of those plans, to produce the literature and all those matters we discussed earlier.